Androstenedione: 4-Androstenedione (androst-4-ene-3,17-dione) ? an endogenous weak androgen and estrogen and intermediate to/prohormone of testosterone.
Androstenedione is used to evaluate the function of the adrenal gland and the ovaries or the testicles as well as the production of hormones related to the development of male sex organs and physical characteristics (androgens). It is most commonly used to determine the cause of symptoms of excess androgens in a woman who has an elevated testosterone level, along with a few other laboratory tests for this purpose.
Androstadienedione (1,4-androstadiene-3,17-dione) is an important industrial precursor for various steroid hormones. Androstadienedione is an important industrial-scale precursor for a wide variety of steroid hormones within the estrane and androstane classifications.
In the report, the data bases on androstenedione and androstadienedione.
This report contains market size and forecasts of Androstenedione in global, including the following market information:
Global Androstenedione Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Androstenedione Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Androstenedione companies in 2021 (%)
The global Androstenedione market was valued at 205.7 million in 2021 and is projected to reach US$ 247.5 million by 2028, at a CAGR of 2.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Androstenedione Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Androstenedione include BIOVET, Indo Phyto Chemicals, Sito Bio, Goto Pharmaceutical, Tianjin King York, Jiufu, Yongning Pharma, Jiangxi Hongyuan Pharmaceutical and Kaizon, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Androstenedione manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Androstenedione Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Androstenedione Market Segment Percentages, by Type, 2021 (%)
Androstenedione
Androstadienedione
Global Androstenedione Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Androstenedione Market Segment Percentages, by Application, 2021 (%)
Arthritis Pharmaceuticals
Fertility Control Pharmaceuticals
Infectious Inflammation Pharmaceuticals
Others
Global Androstenedione Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Androstenedione Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Androstenedione revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Androstenedione revenues share in global market, 2021 (%)
Key companies Androstenedione sales in global market, 2017-2022 (Estimated), (MT)
Key companies Androstenedione sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
BIOVET
Indo Phyto Chemicals
Sito Bio
Goto Pharmaceutical
Tianjin King York
Jiufu
Yongning Pharma
Jiangxi Hongyuan Pharmaceutical
Kaizon
Xi?an Gaoyuan Bio-Chem
Dongyao Pharmaceutical
Huazhong Pharmaceutical
Darui
Danjiangkou Danao
Dahua Pharmaceutical

LEAVE A REPLY

Please enter your comment!
Please enter your name here